Graf Akcie EYEG (Eyegate Pharmaceuticals Inc). Diskuze k akciím EYEG. Aktuální informace EYEG.

Základní informace o společnosti Eyegate Pharmaceuticals Inc (Akcie EYEG)

Skvělé pro velmi rychlou analýzu společnosti. Investor může porovnat různé ukazatele s konkurenčními firmami.

Tržní kapitalizace 13.77M
Hodnota podniku (EV) N/A
Tržby 12.059k
EBITDA N/A
Zisk -9.47
Růst v tržbách Q/Q N/A %
Růst v tržbách Y/Y N/A %
P/E (Cena vůči ziskům) 0.00
Forward P/E -0.16
EV/Sales 1,710.04
EV/EBITDA N/A
EV/EBIT N/A
PEG N/A
Price/Sales 1,141.88
P/FCF N/A
Price/Book 1.97
Účetní hodnota na akcii 0.99
Hotovost na akcii 0.17
FCF vůči ceně -63.33 %
Počet zaměstnanců 14
Tržba na zaměstnance 861.36
Profit margin -67,102.91 %
Operating margin -81,655.54 %
Gross margin 100.00 %
EBIT margin -78,396.20 %
EBITDA margin N/A %
EPS - Zisk na akcii N/A
EPS - Kvartální růst -7.89 %
EPS - Očekávaný růst příští rok -29.55 %
Return on assets -60.03 %
Return on equity -104.96 %
ROIC -63.92 %
ROCE -56.73 %
Dluhy/Equity 1.17
Čistý dluh/EBITDA 2.39
Current ratio 3.07
Quick Ratio 3.07
Volatilita 9.13
Beta 0.80
RSI 50.47
Cílová cena analytiků 10
Známka akcie (dle analytiků) N/A
Insider ownership 3.90 %
Institutional ownership 49.13 %
Počet akcií 12.619M
Procento shortovaných akcií 0.60 %
Short ratio 0.02 %
Dividenda N/A
Procentuální dividenda N/A %
Dividenda/Zisk N/A %
Obchodovaná od 2015
Země United States

Finanční výsledky akcie EYEG

Finanční výsledky společnosti, napoví investorovi, zda se jedná o kvalitní společnost.

# 2020 2019 2018 2017 2016 2015
Revenue$2.686$1.653$0.408$0.669----
Cost Of Goods Sold--------
Gross Profit$2.686$1.653$0.408$0.669----
Research And Development Expenses$5.389$8.056$10.33$8.423$2.717$0.531$1.01$3.034
SG&A Expenses$4.406$4.442$4.636$5.594$3.961$1.931$2.088$2.818
Other Operating Income Or Expenses--------
Operating Expenses$9.795$12.497$14.967$14.016$6.678$2.462$3.098$5.852
Operating Income$-7.109$-10.845$-14.559$-13.347$-6.678$-2.462$-3.098$-5.852
Total Non-Operating Income/Expense$0.108$0.119$-0.001$0.003$-1.71$0.911$-0.585$0.044
Pre-Tax Income$-7.001$-10.725$-14.56$-13.343$-8.388$-1.552$-3.683$-5.808
Income Taxes$0.095$0.086$-1.342-----
Income After Taxes$-7.097$-10.811$-13.218$-13.343$-8.388$-1.552$-3.683$-5.808
Other Income--------
Income From Continuous Operations$-7.097$-10.811$-13.218$-13.343$-8.388$-1.552$-3.683$-5.808
Income From Discontinued Operations--------
Net Income$-7.097$-10.811$-13.218$-13.343$-16.615$-1.774$-3.879$-6.034
EBITDA$-7.057$-10.806$-14.54$-13.342$-6.676$-2.46$-3.093$-5.843
EBIT$-7.109$-10.845$-14.559$-13.347$-6.678$-2.462$-3.098$-5.852
Basic Shares Outstanding32110000
Shares Outstanding32110000
Basic EPS$-2.23$-4.57$-13.94$-22.64$-40.48$-137.93$-315.29$-495.80
EPS - Earnings Per Share$-2.23$-4.57$-13.94$-22.64$-40.48$-137.93$-315.29$-495.80
# 2020 2019 2018 2017 2016 2015
Current Ratio3.05672.1940.57030.56842.76210.0435
Long-term Debt / Capital---0.0025-0.0513--
Debt/Equity Ratio---0.0025-0.0488--0.8861
Gross Margin100100100100--
Operating Margin-264.6702-656.2523-3572.662-1994.272--
EBIT Margin-264.6702-656.2523-3572.662-1994.272--
EBITDA Margin-262.7464-653.9236-3567.928-1993.497--
Pre-Tax Profit Margin-260.659-649.0317-3572.822-1993.763--
Net Profit Margin-264.2106-654.2386-3243.517-1993.763--
Asset Turnover0.26560.11570.02850.0688--
Inventory Turnover Ratio------
Receiveable Turnover553.016389.635517.205712.4321--
Days Sales In Receivables0.664.07221.213929.3594--
ROE - Return On Equity-107.1618-120.9842685.95654050.558-137.80663.8762
Return On Tangible Equity-735.0292-332.2189179.4661231.3504-137.806742.8884
ROA - Return On Assets-70.1774-75.707-92.3981-137.1286-88.2229-110.3122
ROI - Return On Investment-107.1611-120.9837687.69284258.29-137.806742.8884
Book Value Per Share1.62392.9405-1.6741-0.487511.918-268.4955
Operating Cash Flow Per Share2.02022.21737.4775-3.432462.9993167.1442
Free Cash Flow Per Share2.02862.24787.4573-3.451162.9993167.1442